MTEM - スレッシュ・ホ―ルド・ファ―マス―ティカルズ (Molecular Templates Inc.)

MTEMのニュース

   Molecular Templates (MTEM) Investor Presentation - Slideshow  2021/07/16 19:58:33 Seeking Alpha
   The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs  2021/07/15 12:07:56 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) - U.K. antitrust regulators cleared its pending acquisition by AstraZeneca PLC (NASDAQ: AZN ) Bristol-Myers Squibb Company (NYSE: BMY ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Moderna, Inc. (NASDAQ: MRNA ) PLx Pharma Inc. (NASDAQ: PLXP ) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akero Therapeutics, Inc. (NASDAQ: AKRO ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) ( announced a registered direct offering) Allogene Therapeutics, Inc. (NASDAQ: ALLO ) AlloVir, Inc. (NASDAQ: ALVR ) Aptose Biosciences Inc. (NASDAQ: APTO ) Avenue Therapeutics, Inc.
   The Daily Biotech Pulse: ScPharma''s Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues  2021/07/14 11:48:12 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical Holding Company Ltd. . (NYSE: BHVN ) AngioDynamics, Inc. (NASDAQ: ANGO ) (reacted to its fiscal-year 2021 fourth-quarter results) Bicycle Therapeutics plc (NASDAQ: BCYC ) ( announced Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) exercised option to use its tissue-targeted delivery of oligonucleotide therapeutics tech) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Forward Pharma A/S (NASDAQ: FWP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) PLx Pharma Inc. (NASDAQ: PLXP ) (announced availability of FDA-approved liquid-filled aspirin capsules in Walmart Inc. (NYSE: WMT ) stores) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) Unicycive Therapeutics, Inc. (NASDAQ: UNCY ) (IPOed Tuesday) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 13) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc.
   Molecular Templates to Present at the Ladenburg Thalmann 2021 Healthcare Conference  2021/07/06 12:00:00 Intrado Digital Media
AUSTIN, Texas, July 06, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates or MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that it will provide a corporate update and participate in 1-on-1 investor meetings at the Ladenburg Thalmann 2021 Healthcare Conference, to take place July 13-14, 2021.
   Molecular Templates EPS beats by $0.26, misses on revenue  2021/05/13 21:03:09 Seeking Alpha
   Molecular Templates to Participate in Upcoming Virtual Investor Conferences  2020/11/16 21:30:00 GlobeNewswire
AUSTIN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage…
   Oppenheimer Sees These 3 Stocks Skyrocketing Over 100%  2020/11/10 17:42:56 Yahoo Finance
The U.S. presidential election has come to a close, and Wall Street isn’t opposed to the administration change. Last week saw the S&P 500 notch its second-best performance during an election week on record, even as Trump’s chances of getting re-elected became slimer and slimer.Weighing in for Oppenheimer, Chief Investment Strategist John Stoltzfus noted, “What appears clear so far is that the equity markets are not averse to a change of administration stateside at least so long as the Republicans maintain control over the Senate. Checks and balances ‘on the Hill’ have been known to be important to investors over the course of history. The present in our view is no exception.”There is, however, some uncertainty surrounding the Senate, with the two runoff elections for seats in Georgia scheduled for January 5, only 15 days before Inauguration Day. That said, Stoltzfus points out that continued better-than-expected Q3 results from S&P 500-listed companies, economic data tied to job gains and a sharp decline in the unemployment rate have also been helping to prop stocks up.Taking Stoltzfus’ outlook into consideration, we wanted to take a closer look at three stocks earning a round of applause from Oppenheimer, with the firm’s analysts forecasting over 100% upside potential for each.
   Molecular Templates (NASDAQ:MTEM) Rating Lowered to Sell at BidaskClub  2020/10/22 07:42:47 Transcript Daily
Molecular Templates (NASDAQ:MTEM) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports. MTEM has been the subject of a number of other reports. ValuEngine raised shares of Molecular Templates from a “hold” rating to a “buy” rating in a research […]
   BidaskClub Downgrades Molecular Templates (NASDAQ:MTEM) to Sell  2020/10/21 09:36:55 Zolmax News
BidaskClub lowered shares of Molecular Templates (NASDAQ:MTEM) from a hold rating to a sell rating in a research report report published on Tuesday, BidAskClub reports. A number of other equities analysts also recently issued reports on the company. Zacks Investment Research downgraded Molecular Templates from a hold rating to a sell rating in a research […]
   Zacks: Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) to Post -$0.50 Earnings Per Share  2020/10/20 18:37:09 Transcript Daily
Equities research analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM) will announce earnings of ($0.50) per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Molecular Templates’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.46). Molecular Templates posted earnings of ($0.43) per share during the same quarter […]
   Molecular Templates (NASDAQ:MTEM) Rating Lowered to Sell at BidaskClub  2020/10/22 07:42:47 Transcript Daily
Molecular Templates (NASDAQ:MTEM) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports. MTEM has been the subject of a number of other reports. ValuEngine raised shares of Molecular Templates from a “hold” rating to a “buy” rating in a research […]
   BidaskClub Downgrades Molecular Templates (NASDAQ:MTEM) to Sell  2020/10/21 09:36:55 Zolmax News
BidaskClub lowered shares of Molecular Templates (NASDAQ:MTEM) from a hold rating to a sell rating in a research report report published on Tuesday, BidAskClub reports. A number of other equities analysts also recently issued reports on the company. Zacks Investment Research downgraded Molecular Templates from a hold rating to a sell rating in a research […]
   Zacks: Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) to Post -$0.50 Earnings Per Share  2020/10/20 18:37:09 Transcript Daily
Equities research analysts predict that Molecular Templates, Inc. (NASDAQ:MTEM) will announce earnings of ($0.50) per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Molecular Templates’ earnings. The lowest EPS estimate is ($0.56) and the highest is ($0.46). Molecular Templates posted earnings of ($0.43) per share during the same quarter […]
   $6.05 Million in Sales Expected for Molecular Templates, Inc. (NASDAQ:MTEM) This Quarter  2020/10/20 17:28:41 Transcript Daily
Equities analysts expect that Molecular Templates, Inc. (NASDAQ:MTEM) will report $6.05 million in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Molecular Templates’ earnings, with estimates ranging from $5.00 million to $7.85 million. Molecular Templates reported sales of $3.62 million in the same quarter last year, which would suggest a […]
   Molecular Templates (NASDAQ:MTEM) Downgraded by BidaskClub  2020/10/20 02:18:46 Daily Political
Molecular Templates (NASDAQ:MTEM) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Tuesday, BidAskClub reports. A number of other equities research analysts have also issued reports on MTEM. ValuEngine upgraded Molecular Templates from a “hold” rating to a “buy” rating in a research note […]

calendar